- 200 Saginaw Drive
- Redwood City, CA 94063
- United States of America
- P: 650-305-2600
Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.
- Research in Pulmonary Science or Medicine